Teicoplanin Injectable (IV/IM) bulk supplier for pharma manufacturers

Teicoplanin Injectable (IV/IM) Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV/IM)

Available Strengths: 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL

Reference Brands: Targocid (US & EU)

Teicoplanin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacterial lysis. It is effective against gram-positive bacteria, including MRSA. Benefits include long half-life allowing once-daily dosing, rapid bacterial eradication, and safety for severe infections like endocarditis and osteomyelitis, when used properly under supervision.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Teicoplanin Injectable (IV/IM)? List it or send an offer →

Product Description:

Teicoplanin injectable is approved in the EU and US for severe gram-positive bacterial infections, including MRSA. In the EU, brands like Targocid are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, approval is limited, with extraregional use mainly in Europe and Asia. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety. We support seamless market access for teicoplanin IV formulations, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.

Teicoplanin Injectable (IV/IM) — third party manufacturing & bulk supply

Teicoplanin Injectable (IV/IM) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Teicoplanin Injectable (IV/IM) is supplied as Injectable (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Teicoplanin Injectable (IV/IM) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Teicoplanin Injectable (IV/IM) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Teicoplanin Injectable (IV/IM) is listed as Injectable (IV/IM) in 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Teicoplanin Injectable (IV/IM) is referenced against Targocid (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.